Recent Research | Page 9 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Myelodysplastic Syndromes and Iron Chelation Therapy Mar 2017 Mediterr J Hematol Infect Dis myelodysplastic syndromes (MDS)
Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide Mar 2017 Ther Adv Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Feb 2017 Leukemia myelodysplastic syndromes (MDS)
Management of lower-risk myelodysplastic syndromes without del5q: Current approach and future trends Feb 2017 Expert Rev Hematol myelodysplastic syndromes (MDS)
Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes. Feb 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes. Feb 2017 Haematologica myelodysplastic syndromes (MDS)
Outcome of Cyclosporine Monotherapy in Patients of Aplastic Anemia: Experience of a Tertiary Care Hospital in Eastern India. Feb 2017 Indian J Hematol Blood Transfus aplastic anemia
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes. Feb 2017 Mediterr J Hematol Infect Dis myelodysplastic syndromes (MDS)
Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications Feb 2017 Cancer myelodysplastic syndromes (MDS)
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy Feb 2017 Oncotarget myelodysplastic syndromes (MDS)